Ocugen Inc.

09/28/2022 | Press release | Distributed by Public on 09/28/2022 04:35

Ocugen Announces Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in U.S., Europe, and Japan